Related Experiment Videos
[Ex vitro sentinel lymph node mapping in colorectal carcinoma].
Dao-jin Chen1, Feng-qiang Zhou, Yi Gan
1Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, China. chedj@soho.com
Summary
Ex vivo sentinel lymph node (SLN) mapping using methylene blue is feasible for colorectal cancer, accurately predicting lymph node metastasis. This technique helps assess the spread of cancer to nearby lymph nodes.
Area of Science:
- Surgical Oncology
- Pathology
- Medical Imaging
Context:
- Colorectal cancer staging requires accurate assessment of regional lymph node metastasis.
- Sentinel lymph node (SLN) biopsy is a crucial technique for staging.
- Ex vivo mapping offers a novel approach to SLN identification.
Purpose:
- To evaluate the feasibility of ex vivo sentinel lymph node (SLN) mapping with methylene blue staining.
- To determine the clinical value of this technique in predicting regional lymph node metastasis in colorectal cancer.
Summary:
- Methylene blue was injected submucosally around resected colorectal tumors.
- Sentinel lymph nodes were identified, harvested, and pathologically examined.
- The study achieved a 93.8% successful labeling rate with high accuracy (93.3%) in predicting metastasis.
Impact:
- Ex vivo SLN mapping with methylene blue is technically feasible for colorectal carcinoma.
- This method effectively reflects the metastatic status of regional lymph nodes.
- It provides valuable information for accurate cancer staging and treatment planning.